Anniina Snellman

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies (2024)

JAMA Neurology

Mattsson-Carlgren Niklas, Collij Lyduine E., Stomrud Erik, Binette Alexa Pichet, Ossenkoppele Rik, Smith Ruben, Karlsson Linda, Lantero-Rodriguez Juan, Snellman Anniina, Strandberg Olof, Palmqvist Sebastian, Ashton Nicholas J., Blennow Kaj, Janelidze Shorena, Hansson Oskar

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

EJNMMI Research

Alzghool Obada M., Aarnio Richard, Helin Jatta S., Wahlroos Saara, Keller Thomas, Matilainen Markus, Solis Junel, Danon Jonathan J., Kassiou Michael, Snellman Anniina, Solin Olof, Rinne Juha O., Haaparanta‑Solin Merja

(O2 Muu julkaisu )

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Acta Neuropathologica

Lantero-Rodriguez J., Montoliu-Gaya L., Benedet A.L., Vrillon A., Dumurgier J., Cognat E., Brum W.S., Rahmouni N., Stevenson J., Servaes S., Therriault J., Becker B., Brinkmalm G., Snellman A., Huber H., Kvartsberg H., Ashton N.J., Zetterberg H., Paquet C., Rosa-Neto P., Blennow K.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Frontiers in Neurology

Laaksonen Sini, Saraste Maija, Nylund Marjo, Hinz Rainer, Snellman Anniina, Rinne Juha, Matilainen Markus, Airas Laura

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET (2024)

Neurobiology of Disease

Tato-Fernández Claudia, Ekblad Laura L., Pietilä Elina, Saunavaara Virva, Helin Semi, Parkkola Riitta, Zetterberg Henrik, Blennow Kaj, Rinne Juha O., Snellman Anniina

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly (2024)

Alzheimer's Research and Therapy

Koivumäki Mikko, Ekblad Laura, Lantero-Rodriguez Juan, Ashton Nicholas J., Karikari Thomas K., Helin Semi, Parkkola Riitta, Lötjönen Jyrki, Zetterberg Henrik, Blennow Kaj, Rinne Juha O., Snellman Anniina

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation : A 5-year follow-up [11C]PIB-PET study (2024)

Neurobiology of Disease

Pietilä Elina, Snellman Anniina, Tuisku Jouni, Helin Semi, Viitanen Matti, Jula Antti, Rinne Juha O., Ekblad Laura L.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

EJNMMI Research

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease (2024)

Molecular Neurodegeneration

Lantero-Rodriguez Juan, Salvado Gemma, Snellman Anniina, Montoliu-Gaya Laia, Brum Wagner S., Benedet Andrea L., Mattsson-Carlgren Niklas, Tideman Pontus, Janelidze Shorena, Palmqvist Sebastian, Stomrud Erik, Ashton Nicholas J., Zetterberg Henrik, Blennow Kaj, Hansson Oskar

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts (2023)

Alzheimer's Research and Therapy

Lantero-Rodriguez J, Vrillon A, Fernández-Lebrero A, Ortiz-Romero P, Snellman A, Montoliu-Gaya L, Brum WS, Cognat E, Dumurgier J, Puig-Pijoan A, Navalpotro-Gómez I, García-Escobar G, Karikari TK, Vanmechelen E, Ashton NJ, Zetterberg H, Suárez-Calvet M, Paquet C, Blennow K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies (2024)

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET (2024)

Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly (2024)

Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation : A 5-year follow-up [11C]PIB-PET study (2024)

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease (2024)

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts (2023)